Navigation Links
Pharma ChemOutsourcing 2011 Unveils First Wave of 50 Biotech Chemist Speakers for September 12-15 Show in New Jersey
Date:2/14/2011

LONG BRANCH, N.J., Feb. 14, 2011 /PRNewswire/ -- Pharma ChemOutsourcing today launched its 2011 show with the unveiling of the first wave of 50 speakers from a diverse array of biotechnology companies pursuing small molecule drug discovery.  

"The biotechs all have clinical pipelines and their experiences in managing R&D programs with limited capital and human resources demonstrate how they have emerged as the new drug discovery engine," said Mark Alexay, the event organizer.  "Their low-cost business model means they outsource everything except their IP." The speaker list may be found at http://chemoutsourcing.com/speakers.php

"This year only we have implemented a special rate to make the show accessible for all biotechs," continued Alexay.  "Our ultimate goal is to attract chemists from every biotech and medium-sized pharmaceutical company in the world.  To that end we will continue to create very special annual gatherings to meet their needs."  Further pharma and biotech special rate information may be found at http://chemoutsourcing.com/biotech.php

"We already have great relations with the Big Pharma companies like Pfizer, Merck, Bristol-Myers Squibb, and Eli Lilly all of whom we work closely with. In 2011 our efforts are increasingly focused on the members of state biotech association members like those of BioNJ, PA Bio, MassBio, BayBio, and SoCalBio.  The US biotech industry is the world leader - facilitating quality interactions among its leaders is good for business."

Pharma ChemOutsourcing is the annual conference and exhibition focused on US, European, and Asian Sourcing/Outsourcing, Medicinal Chemistry, Process R&D, Chemical Development, Formulation, Finished Products, and new chemical technologies, such as flow chemistry.  China's entry into drug discovery collaborations is one of the hottest 2011 topics. The sessions are held concurrently on 4 parallel tracks and feature 150 speakers. Last year the show attracted 800 attendees and 100 exhibitors.  The 2010 attendee list may be viewed at http://chemoutsourcing.com/attendees.php; the 2011 exhibitor list at http://chemoutsourcing.com/sponsors.php

Every evening is devoted to outdoor receptions and dinners to foster interface among attendees; the 2010 beach party photos may be viewed at http://chemoutsourcing.com/gallery.php

For complete information on Pharma ChemOutsourcing please visit www.chemoutsourcing.com or send us an email at info@chemoutsourcing.com

Related press releases on Pharma ChemOutsourcing's small molecule biotech initiative may be accessed at: http://tinyurl.com/6cctvak

http://tinyurl.com/6czwz3v

CONTACT: Mark Alexay, President, ChemOutsourcing, Apaporis LLC, +1-201-452-4023, malexay@chemoutsourcing.com


'/>"/>
SOURCE Pharma ChemOutsourcing
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Webcast Alert: Isis Pharmaceuticals 2010 Financial Results and Highlights Conference Call
2. Tufts Launches Institute for Biopharmaceutical Partnerships
3. ViroPharma to Participate in the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
4. Genesis Biopharma Announces Management and Board Changes
5. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2010 Financial Results, Guidance for 2011
6. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results
7. Keryx Biopharmaceuticals to Present at 13th Annual BIO CEO and Investor Conference
8. Arena Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference
9. Lexicon Pharmaceuticals to Present at the 13th Annual BIO CEO & Investor Conference
10. Inovio Pharmaceuticals to Present at 13th Annual BIO CEO & Investor Conference
11. Celtic Pharma Announces Presentation of Preclinical Data at the 69th Annual Meeting of the AAD in New Orleans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017  GlobeImmune, Inc. today announced it has ... of 12,835,490 shares of its common stock to NantCell, ... connection with the sale of its common stock, NantCell ... issue to GlobeImmune 200,000 shares, an estimated $2.0 million ... "We are pleased to enter into this strategic agreement ...
(Date:3/23/2017)... NEW YORK , March 23, 2017 ... ... causes of death, putting significant strain on health care systems, ... of cancer diagnoses rises, so too does the development of ... with minimum side effects. Among the many types of cancer ...
(Date:3/23/2017)... ... 23, 2017 , ... Advanced Polymer Monitoring Technologies (APMT), a ... “Sig” Floyd as Vice President ? Global Business Development. Dr. Floyd will lead ... Floyd’s career has spanned 30 years in the chemicals and equipment industries. Sig ...
(Date:3/22/2017)... Calif. , March 22, 2017  UBM ... proud to announce their extended partnership and the ... be headlined by the 21 st Annual ... Boston, taking place May 3-4, 2017. ... Medical Technology Association (ADVAMED) President and CEO, ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Summary ... better understand Merck KGaA and its partnering interests and ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and Alliance ... partnering activity of one of the world,s leading life ... prepared upon purchase to ensure inclusion of the most ...
(Date:2/28/2017)... , February 28, 2017 News solutions for ... ... from 14 to 16 March, Materna will present ... show how seamless travel is a real benefit for passengers. ... biometrics to their passenger touch point solutions to take passengers through ...
(Date:2/22/2017)... LONDON , Feb. 22, 2017 ... by 2021, ABI Research identifies four technologies that ... solutions to secure significant share in the changing ... payments, and passive authentication.   "Companies ... it comes to security," says Dimitrios Pavlakis ...
Breaking Biology News(10 mins):